Featured Research

from universities, journals, and other organizations

Enzyme New Potential Target In Treating Blood Cancer

Date:
August 24, 2008
Source:
Vetenskapsrådet (The Swedish Research Council)
Summary:
A discovery by researchers in Sweden may lead to new treatments for blood cancer and other diseases. By stopping the production of a specific enzyme, ICMT, researchers were able to alleviate disease symptoms in mice with blood cancer.

A discovery by a research team with the Sahlgrenska Academy at Gothenburg University in Sweden may lead to new treatments for blood cancer and other diseases. By stopping the production of a specific enzyme, ICMT, researchers were able to alleviate disease symptoms in mice with blood cancer.

In many forms of cancer, the growth of tumors and their ability to spread are stimulated by a mutated gene that codes for a so-called RAS protein. This has led to intensive research into how to block the activity of these proteins.

“RAS proteins exist in all cells, anchored to the inside of the cell membrane, where they regulate cell growth and cell division. The enzyme we are studying helps RAS proteins get anchored to the cell membrane. By blocking this enzyme, we were able to inhibit the binding of RAS proteins to cell membranes and greatly improve the disease symptoms in mice with blood cancer,” says Associate Professor Martin Bergö, who directs research at the Wallberg? Laboratory at the Sahlgrenska Academy.

The research team has developed a genetically modified mouse that produces a mutated and constantly active RAS protein in its bone marrow, where new blood cells are generated. These mice develop a form of leukemia that is similar to a number of forms of blood cancer in humans. The pathogenic bone marrow cells divide uncontrollably, and the normal control of cell growth cannot turn them off. In these mice, the production of the enzyme called ICMT can also be stopped.

“When we inhibited the production of the enzyme, the development of blood cancer declined, and the uncontrolled growth of bone marrow cells was blocked. Another discovery was that normal bone marrow cells were not significantly affected by the ICMT enzyme. The means that future drugs for inhibiting ICMT could specifically target the pathogenic cells and leave normal cells intact. A drub that blocks this enzyme could be an effective future cancer treatment,” says Martin Bergö.

The research team also demonstrated that mice with an aggressive form of lung cancer lived longer and developed considerably smaller tumors when the ICMT enzyme was blocked. But even though the study strongly indicates that ICMT can be an effective target for cancer treatment, the findings now need to be corroborated by other mice with blood cancer and lung cancer, and drugs to inhibit the enzyme need to be produced and tested.


Story Source:

The above story is based on materials provided by Vetenskapsrådet (The Swedish Research Council). Note: Materials may be edited for content and length.


Journal Reference:

  1. Wahlstrom et al. Inactivating Icmt ameliorates K-RAS-induced myeloproliferative disease. Blood, 2008; 112 (4): 1357 DOI: 10.1182/blood-2007-06-094060

Cite This Page:

Vetenskapsrådet (The Swedish Research Council). "Enzyme New Potential Target In Treating Blood Cancer." ScienceDaily. ScienceDaily, 24 August 2008. <www.sciencedaily.com/releases/2008/08/080821110408.htm>.
Vetenskapsrådet (The Swedish Research Council). (2008, August 24). Enzyme New Potential Target In Treating Blood Cancer. ScienceDaily. Retrieved October 22, 2014 from www.sciencedaily.com/releases/2008/08/080821110408.htm
Vetenskapsrådet (The Swedish Research Council). "Enzyme New Potential Target In Treating Blood Cancer." ScienceDaily. www.sciencedaily.com/releases/2008/08/080821110408.htm (accessed October 22, 2014).

Share This



More Health & Medicine News

Wednesday, October 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Orthodontist Mom Jennifer Salzer on the Best Time for Braces

Orthodontist Mom Jennifer Salzer on the Best Time for Braces

Working Mother (Oct. 22, 2014) — Is your child ready? Video provided by Working Mother
Powered by NewsLook.com
U.S. Issues Ebola Travel Restrictions, Are Visa Bans Next?

U.S. Issues Ebola Travel Restrictions, Are Visa Bans Next?

Newsy (Oct. 22, 2014) — Now that the U.S. is restricting travel from West Africa, some are dropping questions about a travel ban and instead asking about visa bans. Video provided by Newsy
Powered by NewsLook.com
US to Track Everyone Coming from Ebola Nations

US to Track Everyone Coming from Ebola Nations

AP (Oct. 22, 2014) — Stepping up their vigilance against Ebola, federal authorities said Wednesday that everyone traveling into the US from Ebola-stricken nations will be monitored for symptoms for 21 days. (Oct. 22) Video provided by AP
Powered by NewsLook.com
Doctors Help Paralysed Man Walk Again, Patient in Disbelief

Doctors Help Paralysed Man Walk Again, Patient in Disbelief

AFP (Oct. 22, 2014) — Polish doctors describe how they helped a paralysed man walk again, with the patient in disbelief at the return of sensation to his legs. Duration: 1:04 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins